We also envision other bacterial infection-specific biomarkers, such as interleukin-6 (IL-6), can be incorporated into our multiplexed LFA platform to further increase the diagnostic accuracy for differentiating bacterial and viral infections. The gene discussed is IL6; the disease is viral infectious disease.